| 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 生脉胶囊(元) | 180,968,988.56 | 374,970,727.96 | 192,220,008.27 |
| 细辛注射液(元) | 101,151,093.16 | 232,232,369.48 | 114,728,791.66 |
| 其他(元) | 5,506,778.75 | 14,252,482.66 | 5,640,879.14 |
| 营业成本(元) | |||
| 生脉胶囊(元) | 46,140,598.21 | 81,148,934.43 | 42,460,977.22 |
| 细辛注射液(元) | 12,476,197.07 | 24,309,920.30 | 12,433,325.72 |
| 其他(元) | 6,091,064.86 | 13,160,328.48 | 5,570,502.97 |
| 毛利(元) | |||
| 生脉胶囊(元) | 134,828,390.35 | 293,821,793.53 | 149,759,031.05 |
| 细辛注射液(元) | 88,674,896.09 | 207,922,449.18 | 102,295,465.94 |
| 其他(元) | -584,286.11 | 1,092,154.18 | 70,376.17 |
| 毛利率(%) | |||
| 生脉胶囊(%) | 74.50 | 78.36 | 77.91 |
| 细辛注射液(%) | 87.67 | 89.53 | 89.16 |
| 其他(%) | -10.61 | 7.66 | 1.25 |
| 收入构成(%) | |||
| 生脉胶囊(%) | 62.92 | 60.34 | 61.49 |
| 细辛注射液(%) | 35.17 | 37.37 | 36.70 |
| 其他(%) | 1.91 | 2.29 | 1.80 |
| 毛利构成(%) | |||
| 生脉胶囊(%) | 60.48 | 58.43 | 59.40 |
| 细辛注射液(%) | 39.78 | 41.35 | 40.57 |
| 其他(%) | -0.26 | 0.22 | 0.03 |